Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 15)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
8-Feb-10 PriceTarget Research, Inc. N/A ACTS has a current Overall Rating of C (Neutral). 7 $25 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ACTS: the economy's impact on ACTS's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ACTIONS SEMICNDCTR LTD -ADR 5 $25 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ACTIONS SEMICNDCTR LTD -ADR 5 $25 View Abstract
22-Jan-10 Validea N/A Validea Guru Analysis Report for ACTS. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others. N/A $18 View Abstract
17-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ACTIONS SEMICNDCTR LTD -ADR 5 $25 View Abstract
4-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ACTIONS SEMICNDCTR LTD -ADR 5 $25 View Abstract
27-Dec-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ACTIONS SEMICNDCTR LTD -ADR 5 $25 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Industry Report for SEMICONDUCTORS/COMPONENT 19 $49 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for ACTS 13 $25 View Abstract
Next 5

Brokerage Reports (Showing 1 to 1 of 1)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
20-Mar-09 Brean Murray & Co., Inc. Hao Hong Fortnightly Chinese Takeaway: The China Syndrome 6 $30 View Abstract

Independent Reports (Showing 1 to 10 of 14)

Release
Date Contributor Author Title Pages Price More Info
8-Feb-10 PriceTarget Research, Inc. N/A ACTS has a current Overall Rating of C (Neutral). 7 $25 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ACTS: the economy's impact on ACTS's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ACTIONS SEMICNDCTR LTD -ADR 5 $25 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ACTIONS SEMICNDCTR LTD -ADR 5 $25 View Abstract
22-Jan-10 Validea N/A Validea Guru Analysis Report for ACTS. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others. N/A $18 View Abstract
17-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ACTIONS SEMICNDCTR LTD -ADR 5 $25 View Abstract
4-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ACTIONS SEMICNDCTR LTD -ADR 5 $25 View Abstract
27-Dec-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ACTIONS SEMICNDCTR LTD -ADR 5 $25 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Industry Report for SEMICONDUCTORS/COMPONENT 19 $49 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for ACTS 13 $25 View Abstract
Next 4

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.